Is Oscar Health, Inc. overvalued or undervalued?
As of October 10, 2023, Oscar Health, Inc. is considered overvalued due to its high price-to-earnings (45.2), price-to-sales (2.8), and price-to-book (7.1) ratios compared to industry peers, indicating that investors are paying a significant premium relative to its financial metrics.
As of 10 October 2023, Oscar Health, Inc. has moved from fair to overvalued. The company currently exhibits a price-to-earnings ratio of 45.2, a price-to-sales ratio of 2.8, and a price-to-book ratio of 7.1, which are significantly higher than the industry averages. In comparison, peers such as UnitedHealth Group, with a price-to-earnings ratio of 22.5, and Anthem, at 18.7, highlight the premium that Oscar Health is trading at.Given these metrics, Oscar Health appears overvalued in the current market context. The high ratios suggest that investors are paying a substantial premium for the stock relative to its earnings, sales, and book value. This valuation is further reinforced by the recent performance of the stock, which has lagged behind the Sensex, indicating potential concerns among investors regarding its growth prospects.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
